ACN Newswire

Thu Jul 25

Global BioLife Inc.'s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit

Written by ACN Newswire

SINGAPORE, Jul 24, 2019 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd ("SeD", SGX:40V) is pleased to announce the results of clinical trials conducted on Laetose(TM), a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc. ("Global BioLife").

Clinical trial results show that Laetose is...

ACN Newswire

Global BioLife Inc.'s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit

Are There Significant Differences Between Stickers And A Decals?

Public hospital blame game – here's how we got into this funding mess

Here's what the coronavirus pandemic can teach us about tackling climate change

Developing nations need more than words from G20 tax reform

My Name Is Jimi is a four-generation Torres Strait history on stage

Found: the earliest European image of Aboriginal Australians

Morrison sees massive ratings surge in Newspoll over coronavirus crisis; Trump also improves

City share-house rents eat up most of Newstart, leaving less than $100 a week to live on

Female corporate leaders make firms less likely to fall foul of environmental laws

Hernia Truss: Function and Top Benefits for Hernia Treatment

Curious Kids and Imagine This: two neat ways to get young minds thinking this school holiday season